Peijia Medical Limited
PEJMF
$1.39
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 37.17% | 38.80% | 39.41% | 50.87% | 67.32% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 37.17% | 38.80% | 39.41% | 50.87% | 67.32% |
| Cost of Revenue | 54.89% | 55.55% | 54.61% | 51.14% | 47.13% |
| Gross Profit | 30.88% | 32.97% | 34.22% | 50.77% | 75.87% |
| SG&A Expenses | 1.06% | -0.86% | -4.00% | 7.73% | 22.08% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 2.23% | -47.46% | -122.95% | -84.21% | -47.51% |
| Total Operating Expenses | 8.37% | 9.99% | 10.48% | 18.20% | 27.41% |
| Operating Income | 30.61% | 25.21% | 20.99% | 12.32% | 3.67% |
| Income Before Tax | 44.38% | 49.39% | 53.83% | 32.55% | 4.62% |
| Income Tax Expenses | 542.00% | -9.34% | -68.50% | -78.59% | -89.14% |
| Earnings from Continuing Operations | 42.80% | 48.92% | 54.11% | 33.50% | 6.58% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 6,575.00% | 4,416.67% | 70.00% | 270.00% | -- |
| Net Income | 43.28% | 49.12% | 54.11% | 33.51% | 6.58% |
| EBIT | 30.61% | 25.21% | 20.99% | 12.32% | 3.67% |
| EBITDA | 39.91% | 32.00% | 25.36% | 15.44% | 5.60% |
| EPS Basic | 42.18% | 49.02% | 54.54% | 34.13% | 7.47% |
| Normalized Basic EPS | 33.17% | 14.83% | -9.59% | -35.09% | -67.23% |
| EPS Diluted | 42.18% | 49.02% | 54.54% | 34.13% | 7.47% |
| Normalized Diluted EPS | 33.17% | 14.83% | -9.59% | -35.09% | -67.23% |
| Average Basic Shares Outstanding | -1.44% | -0.39% | 0.66% | 0.78% | 0.91% |
| Average Diluted Shares Outstanding | -1.44% | -0.39% | 0.66% | 0.78% | 0.91% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |